Market closedNon-fractional

Jasper Therapeutics/JSPR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Jasper Therapeutics

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Ticker

JSPR

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Redwood City, United States

Employees

45

JSPR Metrics

BasicAdvanced
$335M
Market cap
-
P/E ratio
-$5.52
EPS
2.25
Beta
-
Dividend rate
$335M
2.25
13.493
13.316
1.372
2.255
-33.05%
-53.63%
2.98
2.98
-4.453
-45.18%
10.70%

What the Analysts think about JSPR

Analyst Ratings

Majority rating from 8 analysts.
Buy

JSPR Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$14M
-16.97%
Profit margin
0.00%
NaN%

JSPR Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 15.92%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$1.50
-$1.60
-$1.50
-$1.03
-
Expected
-$1.50
-$1.55
-$1.62
-$1.23
-$1.09
Surprise
0.13%
3.06%
-7.12%
-15.92%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Jasper Therapeutics stock?

Jasper Therapeutics (JSPR) has a market cap of $335M as of July 06, 2024.

What is the P/E ratio for Jasper Therapeutics stock?

The price to earnings (P/E) ratio for Jasper Therapeutics (JSPR) stock is 0 as of July 06, 2024.

Does Jasper Therapeutics stock pay dividends?

No, Jasper Therapeutics (JSPR) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Jasper Therapeutics dividend payment date?

Jasper Therapeutics (JSPR) stock does not pay dividends to its shareholders.

What is the beta indicator for Jasper Therapeutics?

Jasper Therapeutics (JSPR) has a beta rating of 2.25. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Jasper Therapeutics stock

Buy or sell Jasper Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing